In 2009, an article in Monthly Index of Medical Specialities drew attention to a psychiatric drug from Denmark being sold in the Indian market. In the article, the editor of the journal, Dr Chandra ...

Background Patients in chronic somatic diseases are often accompanied with depression and anxiety, remission of which may be observed in the third or fourth week after applying common antidepressant ...

The Drug Technical Advisory Board (DTAB) has formed an expert sub-committee to look into the safety and efficacy of the controversial anti-depressant drug Deanxit, a fixed dose combination (FDC) of ...

Three popular drugs Gatifloxacine, Tesagerod and Deanxit have been banned for their side effects on patients. While in the United Kingdom and United States, there is a caution against using the drug, ...

Even as the controversial drugs nimesulide (for use of below 12 years of age), cisapride, phenylpropanolamine and human placenta extracts are being banned in the country in a matter of some days, ...

The Health Ministry has banned the sale and manufacture of three popular medicines pioglitazone (a popular anti-diabetes drug), analgin (a painkiller) and deanxit (an anti-depressant) after it decided ...

The verdict on whether a ban should be imposed on three drugs ? anti-infective Gatifloxacin, constipation and irritable bowel relieving drug Tegaserod and anti-anxiety drug Deanxit ? in the Indian ...

The government has banned three popular medicines—the widely prescribed anti-diabetes drug pioglitazone, painkiller analgin and anti-depressant deanxit—in the wake of health risks associated with them ...

In fact, Deanxit, along with Analgin and diabetes drug pioglitazone had been suspended in June over safety concerns. But the suspension of pioglitazone has already been revoked, and the drug is back ...

This study assessed the efficiency and efficacy of deanxit used as an adjuvant for short duration combining a SSRIs agent. Response rates on depression and anxiety increased remarkably for patients ...